CTRI/2020/12/029529
Not yet recruiting
Phase 1
The evaluation of imaging modality to determine the ideal treatment modalities in patients with TMJ Dislocation- A prospective clinical study - CBCT- TMJD
OGITHA SRI S0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Health Condition 1: K088- Other specified disorders of teethand supporting structuresHealth Condition 2: M244- Recurrent dislocation of joint
- Sponsor
- OGITHA SRI S
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\)Patients with TMJ Dislocation into study group and normal into control group
- •2\)No previous TMJ surgeries
Exclusion Criteria
- •1\)Patient with previous history of TMJ surgery
- •2\)Patient with age \<18 and \>50
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Evalutation of the patients with localized stricture of MPD without obvious mass in the pancreasPatients with localized MPD stricture without obvious mass in pancreasJPRN-UMIN000039623Kitano Hospital, Tazuke Kofukai Medical Research Institute.30
Active, not recruiting
Phase 1
Phase 2a open label study of Fovista¿ (anti-PDGF agent) administered in combination with anti-VEGF therapy in subjects previously treated or treatment-naive.Subfoveal choroidal neovascularization secondary to Age-Related Macular Degeneration (AMD)MedDRA version: 20.0Level: PTClassification code 10071129Term: Neovascular age-related macular degenerationSystem Organ Class: 10015919 - Eye disordersMedDRA version: 20.1Level: LLTClassification code 10067791Term: Wet macular degenerationSystem Organ Class: 10015919 - Eye disordersTherapeutic area: Diseases [C] - Eye Diseases [C11]EUCTR2015-000519-42-ITIVERIC bio, Inc.32
Active, not recruiting
Phase 1
Role of imaging in the evaluation of anatomic alterations in neovascular Age-Related Macular Degeneration (AMD) subjects: 18 month study of Fovista® (anti-PDGF therapy) administered in combination with anti-VEGF therapySubfoveal choroidal neovascularization secondary to Age-Related Macular Degeneration (AMD)MedDRA version: 18.0 Level: PT Classification code 10071129 Term: Neovascular age-related macular degeneration System Organ Class: 10015919 - Eye disordersMedDRA version: 18.0 Level: LLT Classification code 10067791 Term: Wet macular degeneration System Organ Class: 10015919 - Eye disordersTherapeutic area: Diseases [C] - Eye Diseases [C11]EUCTR2015-000519-42-FROPHTHOTECH CORPORATIO32
Recruiting
Not Applicable
AI-based imaging diagnostic systems for rectal cancerrectal cancerlarge intestine, rectumD012004JPRN-jRCT1040210050Ouchi Akira200
Active, not recruiting
Phase 1
Amyloid imaging in Alzheimer’s disease, frontotemporal dementia and healthy volunteersse of 18F-AV-45 positron emission tomography as early diagnostic technique in frontal lobe dementia and Alzheimer's disease.MedDRA version: 14.0 Level: PT Classification code 10061816 Term: Diagnostic procedure System Organ Class: 10022891 - InvestigationsEUCTR2008-003597-18-GBAvid Radiopharmaceuticals, Inc34